The effect of extract of ginkgo biloba addition to olanzapine on therapeutic effect and antioxidant enzyme levels in patients with schizophrenia.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/16401239
Conclusion of this study
At 8 weeks, there were significant differences in the mean decrease in SOD and CAT levels but not in GPX levels between treatment groups. The changes in SOD and CAT levels were correlated with the change in SAPS in group I, but not in the group II. The present study supported the findings of the previous study demonstrating that EGb might enhance the efficiency of antipsychotic in patients with schizophrenia, particularly on positive symptoms of the disorder.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study